Bookimed does not add extra charges for Topical therapy of melanoma prices. The rates come from the clinics' official price lists. You pay directly at the clinic for your Topical therapy of melanoma upon your arrival.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Topical therapy of melanoma and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Topical therapy of melanoma journey.
| Turkey | Austria | Spain | |
| Topical therapy of melanoma | from $3,250 | - | from $5,727 |
Teknon Hospital (Centro Medico Teknon) is a private medical facility in Barcelona, Spain. World-renowned doctors provide diagnostics and treatment at Teknon.
Epileptology (treatment of epilepsy), neurosurgery, oncology, heart surgery, and stem cell therapy are the primary specialties in Teknon Hospital.
Teknon Hospital is No.1 choice for celebrities, sportsmen, and politicians. Teknon doctors delivered Shakira's baby (famous singer), operated Andres Iniesta (Spanish professional footballer), Thomas Röhler (German athlete competed in the javelin throw), provided stem cell therapy to FC Barcelona football players.
Teknon Clinic is a modern medical center that provides a comprehensive range of medical services. Patients from all over the world can find top-notch care for various medical needs, ranging from online consultations to complex surgeries. Our team of highly qualified doctors and medical coordinators works together to ensure the highest quality of care and patient satisfaction.
The top 5 advantages of Teknon Clinic are:
Day 1
Day 2
Day 3
Day 4
Week 1
Week 2-4
Please note, each patient"s case is unique, and treatment plans may vary.
This doctor has experience in endocrine treatment, collaborating on studies aimed at overcoming resistance to hormone therapy. They have also been involved in numerous phase 1, 2 and 3 studies in breast and melanoma, which have led to the approval of new drugs in new indications. Their main area of interest lies in immunotherapy for melanoma treatment and patient care. They have participated in trials that have led to the approval of cdk4/6 palbociclib and ribociclib inhibitors in the first line of metastatic breast cancer, and Pembrolizumab in the first line of metastatic melanoma, as well as the combination of Nivolumab and Ipilimumab. They are a member of the Breast Cancer Unit and Melanoma Unit at the Vall d'Hebron University Hospital and the Vall d'Hebron Institute of Oncology. This doctor is an experienced oncologist with expertise in breast cancer and melanoma treatments, including endocrine therapy, immunotherapy, and patient care. They have been involved in numerous clinical trials leading to the approval of new drugs in new indications.